Save Time, Save Resources, Save Lives.


ExcitePCR Names Chief Science Officer

May 30, 2017

PLEASANTON, CA – ExcitePCR Corporation has named Dr. Kimothy Smith its Chief Science Officer. Dr. Smith, a recognized biodefense expert, will join Lyle Probst, the CEO of ExcitePCR, to manage the development of Firefly Dx to completion and commercialization, and execute the company’s mission under the U.S. Department of Homeland Security (“DHS”) SenseNet program to provide faster, less expensive bio-threat detection systems while providing an added level of security.  

Dr. Smith served as Senior Advisor for International Biodefense at DHS’ Office of Health Affairs and as Acting Director of the National Biosurveillance Integration Center,...

Read More

ExcitePCR Formed to Better Position Firefly Dx for $19 Billion Global Point-of-Care Diagnostics Market

May 25, 2017

PLEASANTON, CA – ExcitePCR Corporation has been formed to further the development of the Firefly Dx real-time polymerase chain reaction (PCR) breadboard prototype pathogen detection system (“Firefly Dx prototype system”) to provide greater flexibility for strategic partnership and/or financing opportunities.

The Firefly Dx prototype system is designed to be a handheld, fully automated, lab quality, real-time device able to process samples and detect pathogens at the point of need (PON) or point of care (POC), faster and less expensively than existing devices. Firefly Dx's applications include lab-quality, sample processing and detection of...

Read More